183 results on '"Marshall, John"'
Search Results
2. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
3. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
4. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives
5. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease
6. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus
7. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
8. Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation
9. Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease
10. EP1120: GASTROENTEROLOGY FELLOW ESOPHAGEAL MOTILITY & MANOMETRY KNOWLEDGE: ASSESSMENT & IMPROVEMENT INITIATIVE AT AN ACADEMIC CENTER
11. 1159 ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIOME, GUT PERMEABILITY, AND FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVE OF CD PATIENTS
12. 318 ACCEPTABILITY, FEASIBILITY, AND IMPACT OF THE MYGUT DIGITAL HEALTH MONITORING PLATFORM IN THE MONITORING AND MANAGEMENT OF INFLAMMATORY BOWEL DISEASE
13. Sa1796 OPTIMAL ENDOSCOPIC HEALING THRESHOLDS DEFINED BY MM-SES-CD < 22.5 AND SES-CD
14. 902 TOFACITINIB FOR HOSPITALIZED ACUTE SEVERE ULCERATIVE COLITIS - THE TRIUMPH STUDY
15. Tu1838 DELAYED USTEKINUMAB AND ADALIMUMAB RESPONDERS HAVE SIMILAR OUTCOMES AS EARLY RESPONDERS IN BIOLOGIC-NAIVE CROHN'S DISEASE
16. Mo1753 IDENTIFYING BLOOD BIOMARKERS THAT PREDICT INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDY
17. Su1776 EFFICACY AND SAFETY OF ETRASIMOD AS A FIRST-LINE ADVANCED TREATMENT FOLLOWING 5-AMINOSALICYLIC ACID AND/OR THIOPURINES: DATA FROM THE ELEVATE UC 52 AND ELEVATE UC 12 PHASE 3 CLINICAL TRIALS
18. Ozanimod for the Treatment of Ulcerative Colitis
19. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
20. Prevalence of Uninvestigated Dyspepsia 8 Years After a Large Waterborne Outbreak of Bacterial Dysentery: A Cohort Study
21. Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis
22. Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study
23. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines
24. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines
25. Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease
26. Sa484 OUTCOMES OF PASSABLE AND NON-PASSABLE STRICTURES IN CLINICAL TRIALS OF CROHN'S DISEASE: A POST-HOC ANALYSIS
27. Sa467 THE MODIFIED MULTIPLIER SES-CD (MM-SES-CD) PERFORMS BETTER THAN THE SES-CD FOR PREDICTION OF ENDOSCOPIC REMISSION IN CROHN'S DISEASE
28. 393 ASSOCIATION OF PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY
29. 601 INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE
30. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis
31. Sa1799 IL-23 RECEPTOR GENETIC VARIANTS ASSOCIATIONS WITH GUT BARRIER FUNCTION AND MICROBIOME COMPOSITON IN A COHORT OF HEALTY FIRST-DEGREE RELATVIES OF SUBJECTS WITH CROHN'S DISEASE
32. Sa1106 CLOSTRIDIODES DIFFICILE INFECTION IN MECHANICALLY VENTILATED CRITICALLY ILL PATIENTS: A NESTED COHORT STUDY
33. 1234 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY
34. 1233 BILE ACID COMPOSITION, DIETARY FAT, AND CROHN'S DISEASE RISK
35. 1236 FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE FROM MULTIPLEX FAMILIES ARE THREE TIMES MORE LIKELY TO DEVELOP DISEASE AND THIS RISK IS ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION, BUT NOT GENETIC BURDEN
36. 962 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE
37. 634 DIETARY ASSOCIATIONS WITH METABOLITES IMPLICATED WITH CROHN'S DISEASE RISK
38. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
39. Mo1829 HISTOLOGICAL REMISSION DOSE NOT OFFER ADDITIONAL BENEFIT FOR ULCERATIVE COLITIS PATIENTS IN ENDOSCOPIC REMISSION
40. Su1835 WHAT IS THE INCIDENCE OF HERPES ZOSTER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
41. 124 CANADIAN ASSOCIATION OF GASTROENTEROLOGY CLINICAL PRACTICE GUIDELINES ON IMMUNIZATIONS IN INFLAMMATORY BOWEL DISEASE
42. Tu1855 EFFICACY AND SAFETY OF ESCALATION TO TOFACITINIB 10 MG BID FOR PATIENTS WITH UC FOLLOWING LOSS OF RESPONSE ON 5 MG BID MAINTENANCE THERAPY: RESULTS FROM OCTAVE OPEN-LABEL, LONGTERM EXTENSION STUDY
43. Su1980 THE GEM PROJECT: IMPAIRED GUT BARRIER FUNCTION IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CROHN'S DISEASE EVEN IN THE PRESENCE OR ABSCENCE OF PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S PATIENTS
44. Su1853 CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
45. 135 THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS
46. Mo1864 ILEAL AND RECTAL ULCER SIZE IMPACTS ABILITY TO ACHIEVE ENDOSCOPIC REMISSION IN CROHN'S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL
47. Su1860 HIGHER VEDOLIZUMAB SERUM LEVELS DO NOT INCREASE THE RISK OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
48. 96 – Increased Intestinal Permeability is a Predictor of Crohn's Disease Development in a Large Cohort of Asymptomatic First Degree Relatives
49. 366 – Surveillance Colonoscopies in Ulcerative Colitis: Does It Make a Difference?
50. Sa1884 – Unmet Need of Inflammatory Bowel Disease in Canada: Results of a Patient Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.